All analyses
5 min read

Last updated:

High ferritin: why it is almost never iron overload

A ferritin above the reference range triggers the same scene every week: the client arrives worried, someone has said the word hemochromatosis, and sometimes the word bloodletting. In the vast majority of cases, iron is not the issue, and one additional test is enough to settle the direction of the workup.

10 studies citedsee the sources

Benjamin Sant

Co-founder of the School of Longevity

Practitioner reviewing the lab results of a client
Practitioner reviewing the lab results of a client

Ferritin measures iron, but not only iron

Ferritin is the iron storage protein, and its serum level is commonly used to estimate the body's reserves. The problem lies in a second function: it is also an acute phase protein, which rises during inflammation independently of the iron present in the tissues.

A 2023 review calls this rise a persistent enigma: neither the origin of circulating ferritin, nor its release mechanism, nor its effects are established. All that is known is that in an inflammatory setting it can be very high without saying anything about reserves.

That is not a methodological detail. The BRINDA project, which analyzed 15 surveys in 27,865 young children and 8 surveys in 24,844 women, had to build algorithms adjusting ferritin for inflammatory markers to estimate iron deficiency correctly. An earlier study had shown that ferritin, unlike soluble transferrin receptor, is pulled upward by acute phase proteins, with a positive predictive value below 72%.

Transferrin saturation steers the whole workup

A 2026 review sums the situation up in one sentence: hyperferritinemia is common in adults, and most affected people have no iron overload. Confusion between metabolic, inflammatory, genetic and reactive causes leads both to under investigation and to overtreatment.

The test that settles the direction is transferrin saturation. A strategy published as early as 2005 organizes it this way: high saturation, you move toward genetic hemochromatosis and HFE genotyping. Normal or barely changed saturation, you look elsewhere, on the metabolic or inflammatory side, or toward hereditary hyperferritinemia without overload.

One severity marker is worth knowing even if you will probably never meet it in practice. Above 10,000 µg/L, the 2026 review points to hemophagocytic lymphohistiocytosis, an emergency. That threshold has nothing to do with the values slightly above the norm that bring clients into consultation.

The diagnoses found behind a high ferritin

A Korean retrospective study reviewed the records of 2,044 hospitalized patients whose ferritin exceeded 500 ng/ml over a full year, and classified the associated diagnoses.

Solid tumors came first with 37.1% of cases, ahead of infections at 23.4% and hematological diseases at 14.9%. Younger patients had higher ferritin and more hematological causes.

These proportions concern hospitalized patients and do not transpose to a population of healthy people coming for coaching. They say something else, which holds everywhere: a frankly high ferritin most often accompanies an ongoing disease, not an excess of dietary iron.

The most common case in practice is metabolic

In adults who are otherwise healthy, the most common cause of a moderately high ferritin has a little known name. Hyperferritinemia is found in one third of people with nonalcoholic fatty liver disease or metabolic syndrome.

When that hyperferritinemia comes with genuinely increased iron stores, it is called dysmetabolic iron overload syndrome. It affects about 15% of people with metabolic syndrome and half of those with fatty liver disease, which makes it the most frequent iron overload, far ahead of genetic causes.

The temptation is then to offer bloodletting. A randomized trial settled the question in 274 non diabetic patients with this overload, comparing one year of bloodletting plus lifestyle advice against that advice alone. Bloodletting improved neither metabolic nor liver parameters, came with weight gain, and was less well tolerated than expected. The authors conclude that lasting change in diet and lifestyle remains the first intervention.

Hemochromatosis exists, and it is inherited

Setting aside general panic does not mean setting aside the disease. Hereditary hemochromatosis, linked in populations of European ancestry to homozygosity for the C282Y variant of the HFE gene, causes a serious disease that is preventable when detected early.

A 2018 review concludes that severe liver disease, cirrhosis or liver cancer, is not rare in C282Y homozygous men: about one in ten will develop it during their lifetime if the overload is neither detected nor treated. Work on 1,294 homozygous men and 1,596 homozygous women from the UK Biobank, followed for up to fourteen years, shows that this penetrance varies with genetic background, with an odds ratio of 4.90 for fibrosis or cirrhosis between the top 20% and the bottom 20% of polygenic iron scores.

The practical consequence is the same in both directions. A high transferrin saturation in a person whose ferritin is rising calls for medical advice without delay, and family screening of first degree relatives is consensus. A normal saturation, by contrast, justifies neither genotyping nor bloodletting.

What a practitioner who is not a physician can say, and what is off limits

A practitioner who is not a physician does not interpret an iron panel and prescribes nothing. They can, however, do three useful things, and the first is to calm the situation without minimizing: a ferritin above the norm is not synonymous with iron overload, and that is factually true in the great majority of cases.

The second is to check that a second test was actually requested. Reading a ferritin alone, without transferrin saturation, amounts to choosing a direction without the only information that points it the right way. If that test is missing, sending the person back to the physician is the right move.

The third is never to advise cutting dietary iron or going to donate blood to bring the number down. The trial on dysmetabolic overload shows that iron depletion brings nothing metabolic in that situation, and an iron poor diet is paid for elsewhere. Before a high ferritin accompanied by fatigue, joint pain or weight loss the person did not seek, medical referral takes precedence over any nutritional hypothesis.

Sources

  1. 1.Namaste SM, et al. Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Am J Clin Nutr. 2017.
  2. 2.Beard JL, et al. Interpretation of serum ferritin concentrations as indicators of total-body iron stores in survey populations: the role of biomarkers for the acute phase response. Am J Clin Nutr. 2006.
  3. 3.Fonseca Ó, et al. New Perspectives on Circulating Ferritin: Its Role in Health and Disease. Molecules. 2023.
  4. 4.Kim Y, et al. Hyperferritinemia: Pathophysiology, Etiologies, and Diagnostic Approach. Eur J Haematol. 2026.
  5. 5.Aguilar-Martinez P, et al. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities. Am J Gastroenterol. 2005.
  6. 6.Lee LE, et al. Unraveling the differential diagnosis of hyperferritinemia: insights from a retrospective study at a tertiary care hospital. Postgrad Med J. 2025.
  7. 7.Grosse SD, et al. Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Genet Med. 2018.
  8. 8.Pilling LC, et al. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort. Hepatology. 2022.
  9. 9.Rametta R, et al. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities? Curr Pharm Des. 2020.
  10. 10.Lainé F, et al. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. Hepatology. 2017.

Reading studies is one thing, turning them into a plan is another

The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.

See the certification

11 modules, €2,200. Enrol

Benjamin Sant

Co-founder of the School of Longevity

Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.

This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.